Sonoma Pharmaceuticals, Inc. , develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally.
Sonoma Pharmaceuticals stock last closed at $0.16, down 0.63% from the previous day, and has decreased 83.89% in one year. It has underperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.77 percentage points. Sonoma Pharmaceuticals stock is currently +37.07% from its 52-week low of $0.12, and -89.54% from its 52-week high of $1.52.
There are currently 15.61M SNOA shares outstanding. The market value of SNOA is $2.48M. In the last 24 hours, 105,312 SNOA shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy SNOA shares.
Based on our analysis, eToro is the best stock brokerage. eToro gives you:
Get $10 towards your share purchase by signing up for an account with eToro now.
Open eToro AccountNow that you've selected the best brokerage, you need to fill out some personal information so you are able to invest in SNOA stock today.
Now that you have finished signing up on apps for stock market, your next step is to transfer the money for your investment:
Check out the tutorial below for more details depositing funds into your new investment account.
After you have selected the best place to buy Sonoma Pharmaceuticals stock, it's critical to evaluate their stock before you buy, so you can understand the risk and upside.
WallStreetZen was created to help everyday investors perform better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on SNOA's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge SNOA's true value.
Using relative valuations metrics:
You can do additional valuation analysis on SNOA's stock here.
Last year, SNOA revenue was $12.31M. During the past 5 year, SNOA's revenue has grown by -7.57% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 30.65%.
You can analyze SNOA's earnings and revenue performance here.
In the past 12 months, insiders at SNOA have not bought or sold any shares.
Learn more about who owns SNOA shares here.
No, Sonoma Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
You have two primary order types:
Press the Open button and your broker will place your order.
If you want more assistance investing in stocks on eToro, watch the helpful video below:
Now that you own some SNOA stock, you'll want to keep up with your new company.
Start a watchlist to track your SNOA stock.
To reiterate, here are the 6 steps you need to take to buy Sonoma Pharmaceuticals stock right now:
If you are looking for a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you want to keep an eye on your investment in Sonoma Pharmaceuticals, create a watchlist today.